Literature DB >> 1975386

Neurological deterioration in young adults with phenylketonuria.

A J Thompson1, I Smith, D Brenton, B D Youl, G Rylance, D C Davidson, B Kendall, A J Lees.   

Abstract

7 patients with phenylketonuria who developed neurological disability in adolescence or early adult life are described. 4 had been diagnosed by routine neonatal screening and started a low phenylalanine diet in infancy. 3 were diagnosed in early childhood because of developmental delay, and then started dietary treatment. Dietary control deteriorated in later years and was withdrawn in mid to late childhood. The late neurological deterioration cannot be directly ascribed to poor compliance with or cessation of dietary treatment in this small, retrospective study--but other likely causes have been excluded and 2 patients showed a striking clinical improvement when a strict diet was resumed. Serial magnetic resonance images from one of these patients show abnormalities that appeared after cessation of dietary treatment and resolved after diet was resumed. If these findings are confirmed, strict dietary control into adult life would be indicated for at least some patients with phenylketonuria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975386     DOI: 10.1016/0140-6736(90)93401-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  49 in total

1.  Neurological deterioration in adult phenylketonuria.

Authors:  J Weglage; C Oberwittler; T Marquardt; J Schellscheidt; A von Teeffelen-Heithoff; G Koch; H Gerding
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

2.  Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

3.  Neurological improvement following reinstitution of a low phenylalanine diet after 20 years in established phenylketonuria.

Authors:  M S Anwar; B Waddell; J O'Riordan
Journal:  BMJ Case Rep       Date:  2013-07-12

4.  Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet.

Authors:  S Rubin; A L Le Piffer; M B Rougier; M N Delyfer; J F Korobelnik; I Redonnet-Vernhet; C Marchal; C Goizet; S Mesli; C Gonzalez; H Gin; V Rigalleau
Journal:  JIMD Rep       Date:  2013-02-12

5.  Phenylketonuric patients decades after diet.

Authors:  R O Fisch; P N Chang; S Weisberg; P Guldberg; F Güttler; M Y Tsai
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

7.  New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride.

Authors:  Cary O Harding
Journal:  Biologics       Date:  2010-08-09

8.  Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

Authors:  W B Hanley; A S Feigenbaum; J T Clarke; W E Schoonheyt; V J Austin
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study.

Authors:  A M Paans; J Pruim; G P Smit; G Visser; A T Willemsen; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.

Authors:  J Pietz; U K Meyding-Lamadé; H Schmidt
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.